Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review

Rheumatology International

Volumn 36, Issue 3, 2016, Pages 325-331

  Demirkaya, Erkan ^a   Erer, Burak ^b   Ozen, Seza ^c   Ben Chetrit, Eldad ^d  

^a FMF Arthritis Vasculitis and Orphan Disease Research in Pediatric Rheumatology (FAVOR)   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Colchicine; Efficacy; Familial Mediterranean fever; Interferon; Rilonacept; Systematic review

Indexed keywords

COLCHICINE; INTERFERON; RILONACEPT; ANTIINFLAMMATORY AGENT; HYBRID PROTEIN; PLANT EXTRACT;

COCHRANE LIBRARY; DRUG EFFICACY; DRUG SAFETY; EMBASE; FAMILIAL MEDITERRANEAN FEVER; HUMAN; MEDLINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; COLCHICINE; FAMILIAL MEDITERRANEAN FEVER; HUMANS; INTERFERONS; PLANT EXTRACTS; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME;

EID: 84958620599     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-015-3408-9     Document Type: Review

References (24)

1. Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351(9103):659–664
2. Goldfinger SE (1972) Colchicine for familial Mediterranean fever. N Engl J Med 287(25):1302. doi:10.1056/nejm197212212872514
3. Ozkan E, Okur O, Ekmekci A, Ozcan R, Tag T (1972) A new approach to the treatment of periodic fever. Med Bull Istanb 5:44–49
4. Ben-Chetrit E, Levy M (1998) Colchicine: 1998 update. Semin Arthritis Rheum 28(1):48–59
5. Lidar M, Kedem R, Langevitz P, Pras M, Livneh A (2003) Intravenous colchicine for treatment of patients with familial Mediterranean fever unresponsive to oral colchicine. J Rheumatol 30(12):2620–2623
6. Ozturk MA, Kanbay M, Kasapoglu B, Onat AM, Guz G, Furst DE, Ben-Chetrit E (2011) Therapeutic approach to familial Mediterranean fever: a review update. Clin Exp Rheumatol 29(4 Suppl 67):S77–S86
7. Grattagliano I, Bonfrate L, Ruggiero V, Scaccianoce G, Palasciano G, Portincasa P (2014) Novel therapeutics for the treatment of familial mediterranean fever: from colchicine to biologics. Clin Pharmacol Ther 95(1):89–97
8. Schardt C, Adams MB, Owens T, Keitz S, Fontelo P (2007) Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak 7:16. doi:10.1186/1472-6947-7-16
9. Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW (1974) Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med 291(18):934–937. doi:10.1056/nejm197410312911804
10. Goldstein RC, Schwabe AD (1974) Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study. Ann Intern Med 81(6):792–794
11. Wright DG, Wolff SM, Fauci AS, Alling DW (1977) Efficacy of intermittent colchicine therapy in familial Mediterranean fever. Ann Intern Med 86(2):162–165
12. Amaryan G, Astvatsatryan V, Gabrielyan E, Panossian A, Panosyan V, Wikman G (2003) Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard—a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever. Phytomedicine 10(4):271–285. doi:10.1078/094471103322004767
13. Tunca M, Akar S, Soyturk M, Kirkali G, Resmi H, Akhunlar H, Gonen O, Gallimore JR, Hawkins PN, Tankurt E (2004) The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: a double-blind, placebo-controlled trial. Clin Exp Rheumatol 22(4 Suppl 34):S37–S40
14. Hashkes PJ, Spalding SJ, Giannini EH, Huang B, Johnson A, Park G, Barron KS, Weisman MH, Pashinian N, Reiff AO, Samuels J, Wright DA, Kastner DL, Lovell DJ (2012) Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. Ann Intern Med 157(8):533–541. doi:10.7326/0003-4819-157-8-201210160-00003
15. Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, Gafni J (1974) A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med 291(18):932–934. doi:10.1056/nejm197410312911803
16. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 314(16):1001–1005. doi:10.1056/nejm198604173141601
17. Akse-Onal V, Sag E, Ozen S, Bakkaloglu A, Cakar N, Besbas N, Gucer S (2010) Decrease in the rate of secondary amyloidosis in Turkish children with FMF: are we doing better? Eur J Pediatr 169(8):971–974. doi:10.1007/s00431-010-1158-y
18. Ben-Chetrit E, Ben-Chetrit A, Berkun Y, Ben-Chetrit E (2010) Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified? Arthritis Care Res 62(2):143–148. doi:10.1002/acr.20061
19. Goldbach-Mansky R (2012) Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Clin Exp Immunol 167(3):391–404. doi:10.1111/j.1365-2249.2011.04533.x
20. Savic S, Dickie LJ, Wittmann M, McDermott MF (2012) Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives. Best Pract Res Clin Rheumatol 26(4):505–533. doi:10.1016/j.berh.2012.07.009
21. Demirkaya E, Polat A, Basbozkurt G, Gattorno M, Ozen S, Arthritis Vasculitis FMF, Orphan disease Research in Paediatric Rheumatology (FAVOR) (2012) A glance at history and future perspectives of childhood autoinflammatory disorders. Ann Paediatr Rheum 1(1):17–30
22. Brik R, Butbul-Aviel Y, Lubin S, Ben Dayan E, Rachmilewitz-Minei T, Tseng L, Hashkes PJ (2014) Canakinumab for the treatment of children with colchicine-resistant familial Mediterranean fever: a 6-month open-label, single-arm pilot study (Hoboken, NJ). Arthritis Rheumatol (Hoboken, NJ) 66(11):3241–3243. doi:10.1002/art.38777
23. Kalkan G, Demirkaya E, Acikel CH, Polat A, Peru H, Karaoglu A, Sari E, Dursun I, Gok F, Ozen S, Vasculitis FMFA, Orphan Disease Research in Paediatric R (2012) Evaluation of the current disease severity scores in paediatric FMF: is it necessary to develop a new one? Rheumatology (Oxford, England) 51(4):743–748. doi:10.1093/rheumatology/ker421
24. Livneh A (2012) Diagnosis. Severity scoring system for paediatric FMF. Nat Rev Rheumatol 8(6):309–310. doi:10.1038/nrrheum.2012.54